Radicava and Nausea - a phase IV clinical study of FDA data

Summary:

Nausea is reported as a side effect among people who take Radicava (edaravone), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Relyvrio, and have Amyotrophic lateral sclerosis.

The phase IV clinical study analyzes which people have Nausea when taking Radicava. It is created by eHealthMe based on reports of 2,797 people who have side effects when taking Radicava from the FDA, and is updated regularly.

What is Radicava?

Radicava has active ingredients of edaravone. eHealthMe is studying from 2,797 Radicava users. Check the latest studies of Radicava.

What is Nausea?

Nausea (feeling of having an urge to vomit) is found to be associated with 3,891 drugs and 5,634 conditions by eHealthMe. Check the latest studies of Nausea.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 28, 2026

2,797 people reported to have side effects when taking Radicava.
Among them, 57 people (2.04%) have Nausea.

Among these 57 people:

How long have people been on Radicava when they have Nausea? *

What is the gender of people who have Nausea when taking Radicava? *

female: 75.51 %
male: 24.49 %

What is the age of people who have Nausea when taking Radicava? *

What are other drugs people take besides Radicava? *

What are other side effects people have besides Nausea? *

Diarrhea: 12 people, 21.05%
Nausea And Vomiting: 8 people, 14.04%
Fatigue (feeling of tiredness): 7 people, 12.28%
Weakness: 6 people, 10.53%
Abdominal Pain: 5 people, 8.77%
Abdominal Pain Upper: 5 people, 8.77%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 5 people, 8.77%
Gait Disturbance: 5 people, 8.77%
Weight Decreased: 4 people, 7.02%
Dizziness: 4 people, 7.02%

What are the existing conditions these people have? *

Amyotrophic Lateral Sclerosis (nervous system disease that attacks nerve cells called neurons in your brain and spinal cord): 50 people, 87.72%
Hepatocellular Carcinoma (liver cancer): 1 person, 1.75%
Hepatitis C: 1 person, 1.75%
Hepatitis B: 1 person, 1.75%
Fall: 1 person, 1.75%
Autoimmune Disorder (a condition in which the immune system attacks the body's normal substances and tissue): 1 person, 1.75%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 1.75%
Asthma: 1 person, 1.75%

* Approximation only. Some reports may have incomplete information.

Do you take Radicava and have Nausea?

- Check whether Nausea is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Radicava:

Radicava (2,797 reports)

Nausea treatments and more:

Nausea (962,089 reports)

Browse all side effects of Radicava:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Nausea:

Nausea (3,891 drugs)

Browse all the conditions that are associated with Nausea:

Nausea (5,634 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on edaravone (the active ingredients of Radicava) and Radicava (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.